Fundraising FoxKymaThera
2 known investors
Find your way into KymaThera
Sign up to see every warm intro you have to KymaThera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the KymaThera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KymaThera is a biotech company that uses structure-based drug design to develop small molecule therapeutics for cancer and other serious diseases. Its research team focuses on creating differentiated medicines aimed at improving patient outcomes.
Founders & leadership
JM
Jason M. CoxFounder
RK
Rob KaniaFounder
SO
Shawn OuyangFounder
Investors · 2
Frequently asked questions
- What does KymaThera do?
- KymaThera is a biotech company that uses structure-based drug design to develop small molecule therapeutics for cancer and other serious diseases. Its research team focuses on creating differentiated medicines aimed at improving patient outcomes.
- Who are KymaThera's investors?
- KymaThera's investors include Alta Partners, Venrock.